Prescribing intelligence for ADHD therapies
Prescriptions for most CNS stimulants to treat ADHD are increasing. In England there was a 9% year on year growth in prescription items for ADHD with nearly 2 million issued in 2020-2021.
Medications are grouped into 12 hour or 8 hour modified release methylphenidate, immediate release methylphenidate, Lisdexamfetamine, Atomoxetine and Guafacine.
The RxIndex below monitors the performance of all modified release methylphenidate brands, the most frequently prescribed drugs for ADHD.
Additional resources relating to ADHD prescribing
Additional resources coming soon!